Edition:
India

Aytu BioScience Inc (AYTU.OQ)

AYTU.OQ on NASDAQ Stock Exchange Capital Market

3.41USD
19 Jan 2018
Change (% chg)

$-0.22 (-6.06%)
Prev Close
$3.63
Open
$3.61
Day's High
$3.63
Day's Low
$3.17
Volume
19,521
Avg. Vol
--
52-wk High
$6.35
52-wk Low
$2.06

Latest Key Developments (Source: Significant Developments)

Acerus Pharmaceuticals Announces C$1.6 Million Worth Purchase Orders
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Acerus Pharmaceuticals Corporation ::ACERUS PHARMACEUTICALS - ANNOUNCED C$1.6 MILLION WORTH OF NATESTO PURCHASE ORDERS FROM ITS U.S. LICENSEE AYTU BIOSCIENCE.  Full Article

Aytu Bioscience files for mixed shelf of upto $100 mln
Thursday, 23 Nov 2017 

Nov 22 (Reuters) - Aytu Bioscience Inc :Aytu Bioscience Inc files for mixed shelf of upto $100 million - SEC Filing.  Full Article

Aytu Bioscience receives market approval from the Australian therapeutic goods administration for the Mioxsys® system
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Aytu Bioscience Inc ::Aytu Bioscience receives market approval from the Australian therapeutic goods administration for the Mioxsys® system for male infertility.Aytu Bioscience Inc - ‍expects to announce a distribution partner and launch Mioxsys for clinical use in coming quarters​.Aytu Bioscience Inc - ‍has engaged in australian market development activities and is in early discussions with distribution partners​.Aytu Bioscience - ‍Mioxsys been approved by TGA as an aid in diagnostic assessment of semen quality for patients undergoing male infertility evaluation​.  Full Article

Aytu Bioscience CFO Gregory Gould resigns
Saturday, 28 Oct 2017 

Oct 27 (Reuters) - Aytu Bioscience Inc :Aytu Bioscience Inc - ‍on October 26, 2017, Gregory A. Gould resigned as Chief Financial Officer​.Aytu Bioscience Inc - ‍Gould's resignation will become effective on November 15, 2017 -​ SEC filing.  Full Article

Aytu BioScience announces pricing of $7.5 million public offering of common stock and warrants
Tuesday, 3 May 2016 

Aytu BioScience Inc:Says it has priced an underwritten public offering of 18,750,000 shares of its common stock and warrants to purchase up to an aggregate of 18,750,000 shares of its common stock.Gross proceeds from the offering to Aytu are expected to be approximately $7.5 million.Also has granted the representative of the underwriters a 45-day option to purchase up to an additional 2,812,500 shares and/or 2,812,500 additional warrants.Offering is expected to close on May 6, 2016, subject to satisfaction of customary closing conditions.  Full Article

BRIEF-Aytu Bioscience Appoints David Green As CFO

* AYTU BIOSCIENCE ANNOUNCES APPOINTMENT OF DAVID GREEN AS CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage: